Tradestie Institutional Equity Comparison Engine
NBP vs ANRO โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ANRO Overall Edge
ANRO Captures Institutional Edge (3โ1 Pillars ยท 3โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Alto Neuroscience Inc. (ANRO) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while NBP counters with relative strength in Valuation. Fundamentally, NBP trades at 2.7x Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus ANRO at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, NBP sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ANRO sits in CONSOLIDATION (8th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
NBP
NBP 2.7x vs ANRO N/M Fwd P/E
Growth & Margin Winner
ANRO
Op Margin 0.0% vs 0.0% ยท YoY +0.0% vs +0.0%
Momentum & Technical Winner
ANRO
1Y -81.0% vs +143.0% ยท 52W Pos 0% vs 63%
Options & Structure Winner
ANRO
UNCLASSIFIED (N/A IV) vs CONSOLIDATION (8th %ile IV)
NBP
US Equity
NBP
Institutional Equity
$0.79
-6.66% 1D
Market Cap
$96.3M
1M Return
-37.04%
1Y Return
-80.98%
Forward P/E
2.7x
Unified AI Score
51.9 / 100
HOLD
Tech 60.0
Fund 50.0
Flow 50.0
Mom 55.0
ANRO
NYSE
Alto Neuroscience Inc.
Pharmaceutical Preparations
$27.59
-6.62% 1D
Market Cap
$1.2B
1M Return
+25.73%
1Y Return
+143.04%
Forward P/E
N/M
Unified AI Score
29.3 / 100
SELL
Tech 50.0
Fund 34.0
Flow 65.0
Mom 40.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
NBP -80.98%
ANRO +143.04%
Spread: +224.02 pp (ANRO Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
NBP TTM Op. Margin: 0.0%
ANRO TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on NBP vs ANRO. Trailing 12-month operating profitability (NBP 0.0% vs ANRO 0.0%) and valuation multiples (NBP 2.7x vs ANRO N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | NBP | ANRO | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $96.3M | $1.2B | Larger Scale | ANRO |
| Trailing P/E Ratio Valuation | 2.7x | N/M | Lower Multiple | NBP |
| Forward P/E Ratio Valuation | 2.7x | N/M | Lower Multiple | NBP |
| Revenue Growth (YoY) Growth | +0.0% | +0.0% | Higher Growth | Tie |
| Operating Margin (TTM) Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -59.1% | -46.7% | Higher ROE | ANRO |
| 52-Week Range Position Momentum | 0% ($1โ$5) | 63% ($11โ$37) | Stronger Trend | ANRO |
| Beta / 30D Volatility Risk Regime | 1.66ฮฒ ยท 81% Vol | 1.95ฮฒ ยท 89% Vol | Lower Realized Risk | NBP |
| Unified Institutional Score Composite Signal | 51.9 / 100 (HOLD) | 29.3 / 100 (SELL) | Higher Composite | NBP |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full NBP vs ANRO Buy Guide
NBP
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
ANRO
CONSOLIDATION
57d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
8th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither NBP nor ANRO registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.